跳至主要内容
临床试验/NCT04369300
NCT04369300Unknown不适用

Prevalence Of Anxiety And Depression During COVID-19

Max Healthcare Insititute Limited1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年4月24日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
1
主要终点
prevalence (magnitude) of depression and anxiety of general adult population during COVID 19

研究概览

简要总结

  1. To understand the prevalence of symptoms of Depression and Anxiety in general population during COVID-19 in India
  2. To understand correlation between COVID-19 related factors and mental health symptomology in the general population in India

Hypothesis:

There is likelihood of significant symptoms of depression and anxiety among general population in India during the current COVID-19 outbreak.

Procedure:

The participants would be selected with their informed consent. The objective of the study would be clearly written on Page 1 of the survey. The test would be administered electronically by all the participants individually only when consented to the study. The data collected will be kept strictly confidential and the identity of the participants will not be disclosed at any point of the research

Measures:

  1. Demographic Information Demographic variables included Gender, Age, Place of Stay, Marital Status, Highest Level ofEducation, current living arrangement (e.g. staying alone or with family) and Occupation. It further includesregular employment status and current employment status(e.g, Work from home, temporary leave, termination etc)
  2. History of illness (Present or past) History of physical ailment specified (diabetes, hypertension, heart ailment or being on any steroid or any other chronic ailment) Previous history of H1N1/ Influenza like illness
  3. COVID-19 Information This section includes time spent focusing on COVID related information, current stressors with respect to COVID-19 and coping mechanisms used. This further includesinformation on resources available to participants near their place of stay and information of any known diagnosed case of COVID-19.
  4. Standardized Scales to be used Generalized Anxiety Disorder Scale (GAD-7); Patient Health Questionnaire (PHQ-9) Powered by

详细描述

Aim:

  1. To understand the prevalence of symptoms of Depression and Anxiety in general population during COVID-19 in India
  2. To understand correlation between COVID-19 related factors and mental health symptomology in the general population in India

Hypothesis:

There is likelihood of significant symptoms of depression and anxiety among general population in India during the current COVID-19 outbreak.

Procedure:

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants of the age of 18 years and above
  • Participants residing in India
  • Participants with minimum 10 years of education with basic knowledge of English

排除标准

  • Participants under the age of 18 years
  • Participants residing outside of India
  • Participants with previous history of any major psychiatric illness, psychiatric hospitalization or currently on any psychiatric medication.

结局指标

主要结局

prevalence (magnitude) of depression and anxiety of general adult population during COVID 19

时间窗: 1 Year

To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Patient Health Questionnaire (PHQ-9).

Prevalence (magnitude) of anxiety of general adult population during COVID-19

时间窗: 1 YEAR

To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Generalized Anxiety Disorder Scale (GAD-7)

次要结局

未报告次要终点

研究者

发起方
Max Healthcare Insititute Limited
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验